Amarin | AMRN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 290M 51M 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
DBV Technologies USD 274M 17M 2025-09
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 292.21B 26.55B 2025-12